<ARTICLE>5 <LEGEND> Exhibit 27 for Bristol-Myers Squibb </LEGEND> <MULTIPLIER>1000000 <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> Dec-31-1995 <PERIOD-END> Jun-30-1995<F1> <CASH> 1,719 <SECURITIES> 583 <RECEIVABLES> 2,234<F2> <ALLOWANCES> 0 <INVENTORY> 1,472 <CURRENT-ASSETS> 6,890 <PP&E> 6,073 <DEPRECIATION> 2,329 <TOTAL-ASSETS> 13,579 <CURRENT-LIABILITIES> 4,399 <BONDS> 679 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 54 <OTHER-SE> 6,157 <TOTAL-LIABILITY-AND-EQUITY> 13,579 <SALES> 6,746 <TOTAL-REVENUES> 6,746 <CGS> 1,786 <TOTAL-COSTS> 1,786 <OTHER-EXPENSES> 1,359 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 45 <INCOME-PRETAX> 1,870 <INCOME-TAX> 530 <INCOME-CONTINUING> 1,264 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 1,264 <EPS-PRIMARY> 2.49 <EPS-DILUTED> 0 <FN> <F1> Items reported as "zero" are not applicable or are immaterial to the consolidated financial position of the Company. <F2> Receivables are reported net of allowances for doubtful accounts.